Supply Chain and Outsourcing

The mRNA Revolution

Amisha Patel, Sanofi

PDA Manufacturing Meets Legislation

Dr. Bettine Boltres and Ana Marques Kuschel, PhD, WEST Pharmaceutical Services

The High Cost of Cheap Drugs

Martin VanTrieste, Civica Rx

A Comprehensive Review of Regulatory Intelligence: Exploring Tools and Program Maturities

Jason Kerr, Moderna , Katie Bevard, Eli Lilly , and Maria Jacobs, PhD, Pfizer, Inc.

2023 PDA Quality & Regulations Conference

Patrick Costello, AbbVie Pharmaceuticals, and Vinny Browning, Amgen (Co-Chairs)

Testing of the Future

Heike Merget-Millitzer, PhD, Janssen Inc.

Think Big, Leverage and Cooperate to Get COVID-19 Vaccines to People Faster

Martin Van Trieste, President & CEO, Civica Rx

Keeping Biopharma’s Essential Services Lifeline Afloat during COVID

Subrata Chakraborty, GxPFONT Consulting Group

Pharma Firm Explores RFID for Prefilled Syringes

Gabriele Peron, Stevanato Group

4 Ways to Manage Your Supply Chain and Mitigate Drug Shortages

Dawn MacNeill, MilliporeSigma

Guest Editorial: We Should Expect Drug Shortages to Get Worse

Martin VanTrieste, President & CEO, Civica Rx

Reclaiming Efficiency Amid Serialization Nightmares

Vito Pirrera and John Jordon, Vantage Solutions

A Not-So-Sweet Smell: Part II

Anthony Newcombe, PhD, PAREXEL Consulting and Siegfried Schmitt, PAREXEL Consulting

AIDC is a Sign of Things to Come: Part I

Napoleon Monroe, New Directions Consulting

Knowledge is Power

Rafik H. Bishara, PhD, Eli Lilly and Company (retired) and Erik van Asselt, PhD, MSD